Press release
Insights on the Heterozygous Familial Hypercholesterolemia Drug Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027
The global heterozygous familial hypercholesterolemia drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Heterozygous familial hypercholesterolemia (HeFH) is an inherited genetic disorder. It causes high cholesterol levels that lead to heart disease, heart attack, or stroke. Additionally, HeFH is one form of Familial Hypercholesterolemia (FH). The major factor driving the demand for the heterozygous familial hypercholesterolemia drug is the increasing prevalence of familial hypercholesterolemia across the globe.According to Medline Plus, familial hypercholesterolemia affects an estimated 1 in 200 to 1 in 250 people in most countries. Additionally, it is the most common inherited condition affecting the heart and blood vessels. Furthermore, the condition occurs more frequently in certain populations that include Afrikaners in South Africa, Lebanese, and Tunisians. Hence, the increasing prevalence of familial hypercholesterolemia is driving the demand for heterozygous familial hypercholesterolemia drugs for treatment which in turn is driving the growth of the market.
To Request a Sample of our Report on Heterozygous Familial Hypercholesterolemia Drug Market: https://www.omrglobal.com/request-sample/heterozygous-familial-hypercholesterolemia-drug-market
Some major players in the market include Sanofi SA, Amgen Inc., and Novartis International AG, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in September 2021, Amgen announced the approval of Repatha (evolocumab) from the US Food and Drug Administration (FDA). It is used as an adjunct to diet and other low-density lipoprotein cholesterol (LDL-C)-lowering therapies for the treatment of heterozygous familial hypercholesterolemia (HeFH) in pediatric patients aged 10 years and older.
Market Coverage
· The market number available for - 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
Segment Covered-
· By Product Type
· By Application
Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
Competitive Landscape- Sanofi SA, Amgen Inc., and Novartis International AG, among others.
(Get 15% Discount on Buying this Report)
A full Report of Heterozygous Familial Hypercholesterolemia Drug Market is Available @ https://www.omrglobal.com/industry-reports/heterozygous-familial-hypercholesterolemia-drug-market
Global Heterozygous Familial Hypercholesterolemia Drug Market Report by Segment
By Type
• Gemcabene Calcium
• MGL-3196
• ST-103
• Others
By Application
• Hospital
• Medical Center
• Clinics
• Others
Global Heterozygous Familial Hypercholesterolemia Drug Market Report by Region
Regional Analysis
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insights on the Heterozygous Familial Hypercholesterolemia Drug Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027 here
News-ID: 2575956 • Views: …
More Releases from Orion Market Research
Stuffed Animal & Plush Toys Market Size Trends and Forecast by Application, Type …
The Global Stuffed Animal & Plush Toys Market is projected to reach around USD 27.5 billion by 2033, growing at a compound annual growth rate (CAGR) of approximately 8.2% from 2024 to 2033.
Stuffed Animal & Plush Toys Market Overview
The Global Stuffed Animal & Plush Toys Market encompasses a wide range of soft, cuddly toys designed for children and collectors alike. These toys serve not only as playthings but also as…
Robotic Camera Systems Market : A Guide to Understanding the Process
The global robotic camera systems market was valued at approximately USD 1.2 billion in 2023 and is projected to reach around USD 3.5 billion by 2033, growing at a compound annual growth rate (CAGR) of about 12.7% from 2024 to 2033.
Robotic Camera Systems Market Overview
The robotic camera systems market is experiencing significant growth driven by advancements in automation, artificial intelligence, and the increasing demand for high-quality visual content across various…
Otoscope Market Size Future Scope, Demands and Projected Industry Growths to 203 …
The global otoscope market was valued at approximately USD 181.8 million in 2023 and is projected to reach USD 332.5 million by 2033, growing at a compound annual growth rate (CAGR) of about 4.22% from 2024 to 2033.
Otoscope Market Overview
The otoscope market is experiencing steady growth driven by increasing demand for diagnostic tools in ear health, advancements in medical technology, and the rising prevalence of ear-related conditions. Otoscopes, essential for…
Scissor Lift Table Market Estimated to Experience a Hike in Growth by 2033
The Global Scissor Lift Table Market is projected to reach around USD 3.0 billion by 2033, growing at a compound annual growth rate (CAGR) of approximately 7.2% from 2024 to 2033.
Scissor Lift Table Market Overview
The Global Scissor Lift Table Market encompasses equipment designed to raise and lower heavy loads, facilitating efficient material handling across various industries. These lift tables are integral in manufacturing, warehousing, logistics, and construction sectors, enhancing productivity…
More Releases for Heterozygous
Heterozygous Familial Hypercholesterolemia Management Market Size Projected To R …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the Heterozygous Familial Hypercholesterolemia Management Market?
The market for managing heterozygous familial hypercholesterolemia has seen a swift expansion in recent years. It is projected to increase from $10.84 billion in 2024 to $12.07 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.3%. This…
Heterozygous Familial Hypercholesterolemia Drug Market - Industry Trends and For …
The Heterozygous Familial Hypercholesterolemia (HeFH) Drug market was valued at USD 14.6 billion in 2023 and is projected to reach approximately USD 27.6 billion by 2033, growing at an estimated CAGR of around 6.7% from 2024 to 2033.
Heterozygous Familial Hypercholesterolemia Drug Market Overview
The Heterozygous Familial Hypercholesterolemia Drug market is witnessing steady growth driven by increasing diagnosis rates and advancements in lipid-lowering therapies. The emergence of biologics, such as PCSK9 inhibitors…
Comprehensive Heterozygous Familial Hypercholesterolemia Management Market Insig …
What combination of drivers is leading to accelerated growth in the heterozygous familial hypercholesterolemia management market?
The rising prevalence of cardiovascular diseases (CVDs) is expected to propel the growth of the heterozygous familial hypercholesterolemia management market. CVDs include a range of heart and blood vessel disorders, such as coronary artery disease, heart failure, and stroke. The global increase in CVDs is due to rising risk factors such as poor lifestyle choices,…
Heterozygous Familial Hypercholesterolemia Drug Market Comprehensive Industry Tr …
The Heterozygous Familial Hypercholesterolemia (HeFH) Drug market is experiencing significant growth, driven by increasing awareness of cardiovascular diseases and the urgent need for effective cholesterol-lowering therapies. HeFH is a genetic condition that leads to elevated levels of low-density lipoprotein (LDL) cholesterol, raising the risk of heart disease. As healthcare systems aim to combat the rising prevalence of cardiovascular disorders, the demand for innovative treatments for HeFH is at an all-time…
Heterozygous Familial Hypercholesterolemia Drug Market Worldwide Industry Analys …
Heterozygous familial hypercholesterolemia drug market is anticipated to grow at a significant CAGR during the forecast period. Heterozygous familial hypercholesterolemia (HeFH) is an inherited genetic disorder. It causes high cholesterol levels that lead to heart disease, heart attack, or stroke. Additionally, HeFH is one form of Familial Hypercholesterolemia (FH). The major factor driving the demand for the heterozygous familial hypercholesterolemia drug is the increasing prevalence of familial hypercholesterolemia across the…
Heterozygous Familial Hypercholesterolemia Management Market to Witness Astonish …
The "Heterozygous Familial Hypercholesterolemia Management Market" report will provide one with overall market analysis, statistics, various trends, drivers, opportunities, restraints, and every minute data relating to the market necessary for forecasting its revenue, factors propelling & growth. The Heterozygous Familial Hypercholesterolemia Management market study provides unique guidance in thoughtful details regarding the development factors and has used a top-down and bottom-up approach to keep it error-free and accurate. Our expert…
